Bioxytran, Inc.
General ticker "BIXT" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $7.4M (TTM average)
Bioxytran, Inc. does not follow the US Stock Market performance with the rate: -37.6%.
Estimated limits based on current volatility of 7.6%: low 0.07$, high 0.08$
Factors to consider:
- Total employees count: 5000 as of 2009
- Top business risk factors: Liquidity and credit risks, Economic downturns and volatility, Capital raising, Limited resources, Operational and conduct risks
- Price in estimated range
- Earnings for 18 months up through Q2 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.06$, 0.22$]
- 2024-12-30 to 2025-12-30 estimated range: [0.05$, 0.18$]
Short-term BIXT quotes
Long-term BIXT plot with estimates
Financial data
| YTD | 2023-12-31 |
|---|---|
| Operating Revenue | $0.00MM |
| Operating Expenses | $3.82MM |
| Operating Income | $-3.82MM |
| Non-Operating Income | $-0.55MM |
| Interest Expense | $0.54MM |
| R&D Expense | $1.15MM |
| Income(Loss) | $-4.37MM |
| Profit(Loss)* | $-4.28MM |
| Stockholders Equity | $-2.43MM |
| Assets | $0.14MM |
| Operating Cash Flow | $-0.78MM |
| Capital expenditure | $0.04MM |
| Investing Cash Flow | $-0.04MM |
| Financing Cash Flow | $0.55MM |
| Earnings Per Share** | $-0.03 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.